Since NFk-B signaling is thought to be a key mechanism connecting inflammation in HCC, it is hypothesised that nimbolide may regulate cell proliferation by inhibiting this pathway (77, 78). This evidence concerns the gene NFKB1 and hepatocellular carcinoma.